Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular

Texture feature by FDG PET can predict events of cardiac sarcoidosis

Osamu Manabe, Kazuhiro Koyanagawa, Kenji Hirata, Tadao Aikawa, Hiroshi Ohira, Noriko Oyama-Manabe, Sho Furuya, Masanao Naya, Ichizo Tsujino and Nagara Tamaki
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 372;
Osamu Manabe
3Hokkaido University Sapporo Japan
5Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Koyanagawa
2Depertment of Cardiovascular Medicine Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Hirata
1Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadao Aikawa
6Hokkaido University Graduate School of Medicine Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Ohira
3Hokkaido University Sapporo Japan
5Hokkaido University Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Oyama-Manabe
9Japan Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sho Furuya
7Hokkaido university hospital Sapporo City Kita 9 jo Higashi 1 Chome N9 301 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanao Naya
4Hokkaido University Hokkaido Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ichizo Tsujino
8Internal Medicine I, Hokkaido University Hospital Sapporo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagara Tamaki
10Kyoto Prefectural University of Medicine Kyoto Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

372

Purpose: FDG PET plays a significant role in the assessment of cardiac sarcoidosis (CS). Texture analysis has a possibility to assess FDG cardiac uptake in depth. Our aim was to investigate whether texture analysis applied to myocardial FDG uptake has a prognostic value in patients with CS.

Methods: We retrospectively analyzed patients who were diagnosed as CS based on Japanese Society of Sarcoidosis and Other Granulomatous disorders (JSSOG) guideline. Patient who had already oral steroid treatment prior to the FDG PET/CT scan was excluded. A total of 62 patients given over 18 hours fasting prior to FDG injection were studied. The median age of the patients was 64 (interquartile range, 55-71) years and 14 patients (22.5%) were men. Approximately 4.5 MBq/kg (body weight) of FDG was intravenously administrated under a resting condition. A static PET scan was performed 60 min after the administration of FDG. All PET/CT imaging was performed using a Biograph 64 TruePoint TrueV scanner (Siemens Japan, Tokyo). Semi-quantitative FDG PET parameters such as maximal standard uptake value (SUVmax), cardiac metabolic volume (CMV) and cardiac metabolic activity (CMA) were estimated as previously reported (ref 1). Texture features were computed using polar map images (ref 1). Among the several textural features, Homogeneity, Entropy and high gray-level run emphasis (HGRE) were selected as they were found to be robust with respect to the delineation method and were not highly correlated one with another (ref 2). The primary endpoint of this study was composite of major adverse cardiac events (MACE) such as all cause death, sustained VT (SVT), ventricular fibrillation (VF), advanced atrioventricular (AV) block, and hospitalization due to worsening of heart failure. In patients with implantable cardiac defibrillators (ICDs), device interrogation records were used to identify any ventricular arrhythmias requiring cardioversion or anti-tachycardia pacing. We analyzed the effects of FDG PET parameters on MACEs among patients with CS. Multivariate analysis was performed with a selection of variables among gender, New Your Heart Association (NYHA) classification, left ventricular ejection fraction (LVEF), steroid treatment after PET scan, SUVmax, CMV, CMA and texture features identified as significant on univariate analyses (P < 0.05) using Cox proportional-hazards regression model with likelihood ratio test.

Results: During the median of 3.1 years (interquartile range, 2.1 - 4.7 years) of follow-up, MACE occurred in 15 patients. Age, LVEF, the frequency of male and diabetes mellitus showed no significant difference between the patients with and without MACE. No significant differences were found in SUVmax, CMV, CMA, Homogeneity and Entropy, however, HGRE was significantly higher in the patient with MACE compared to the patient without MACE (1078 [914-1532] vs. 838 [706-1056], P = 0.004). Kaplan-Meier curves constructed from HGRE values showed the statistical significance by log-rank test (P < 0.05) (Figure). A univariate analysis showed that NYHA classification (hazard ratio [HR]; 1.7, 95% confidential interval [CI]; 1.0-2.9, P = 0.048), LVEF (HR; 0.96, 95% CI 0.9-1.0; P = 0.026) and HGRE (HGRE/100 - HR; 1.15, 95% CI; 1.02-1.27, P = 0.022) were significantly associated with MACE. Multivariate Cox proportional hazard regression analysis demonstrated that HGRE was the significant predictor of MACE (P < 0.05).

Conclusions: Textural feature obtained with FDG PET/CT can provide independent prognostic information complementary to semi-quantitative assessment for patients with CS. Reference 1. Manabe O et al. Use of 18F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2018 Oct 16. doi: 10.1007/s00259-018-4195-9. 2. Orlhac F et al. Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med. 2014 Mar;55(3):414-22.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Texture feature by FDG PET can predict events of cardiac sarcoidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Texture feature by FDG PET can predict events of cardiac sarcoidosis
Osamu Manabe, Kazuhiro Koyanagawa, Kenji Hirata, Tadao Aikawa, Hiroshi Ohira, Noriko Oyama-Manabe, Sho Furuya, Masanao Naya, Ichizo Tsujino, Nagara Tamaki
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 372;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Texture feature by FDG PET can predict events of cardiac sarcoidosis
Osamu Manabe, Kazuhiro Koyanagawa, Kenji Hirata, Tadao Aikawa, Hiroshi Ohira, Noriko Oyama-Manabe, Sho Furuya, Masanao Naya, Ichizo Tsujino, Nagara Tamaki
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 372;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular

  • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
  • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
Show more Cardiovascular

Cardiovascular Clinical Science: Infiltrative Cardiomyopathies and Infection Imaging

  • Michael Oien MD
  • Objective assessment of left ventricular assist device infection by 18F-FDG PET/CT
  • FMISO PET/CT detects hypoxia lesions in cardiac and extra-cardiac sarcoidosis.
Show more Cardiovascular Clinical Science: Infiltrative Cardiomyopathies and Infection Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire